These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7624836)

  • 41. Total steroidal alkaloids from Veratrum patulum L. Inhibit platelet aggregation, thrombi formation and decrease bleeding time in rats.
    Song Q; Wang S; Zhao W
    J Ethnopharmacol; 2012 May; 141(1):183-6. PubMed ID: 22366682
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antithrombotic effects of the novel inhibitor of thrombin-induced offtelet aggregation and thrombus formation, 3-[2-[1,1':2',1"]-terphenyl-4'-yl)ethyl]phenoxyacetic acid.
    Miyamae T; Hashizume H; Ogawa T; Okayama T; Nukui E; Oshima K; Morikawa T; Hagiwara M
    Arzneimittelforschung; 1997 Jan; 47(1):13-8. PubMed ID: 9037437
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative genomics of two Asian medicinal leeches Hirudo nipponia and Hirudo tianjinensis: With emphasis on antithrombotic genes and their corresponding proteins.
    Zhao F; Huang Z; He B; Liu K; Li J; Liu Z; Lin G
    Int J Biol Macromol; 2024 Jun; 270(Pt 1):132278. PubMed ID: 38750856
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enzyme from the medicinal leech (Hirudo medicinalis) that specifically splits endo-epsilon(-gamma-Glu)-Lys isopeptide bonds: cDNA cloning and protein primary structure.
    Fradkov A; Berezhnoy S; Barsova E; Zavalova L; Lukyanov S; Baskova I; Sverdlov ED
    FEBS Lett; 1996 Jul; 390(2):145-8. PubMed ID: 8706846
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Saratin, an inhibitor of von Willebrand factor-dependent platelet adhesion, decreases platelet aggregation and intimal hyperplasia in a rat carotid endarterectomy model.
    Cruz CP; Eidt J; Drouilhet J; Brown AT; Wang Y; Barnes CS; Moursi MM
    J Vasc Surg; 2001 Oct; 34(4):724-9. PubMed ID: 11668330
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Polyfunctionality of destabilase, a lysozyme from a medicinal leech].
    Baskova IP; Zavalova LL
    Bioorg Khim; 2008; 34(3):337-43. PubMed ID: 18672682
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Methods and models to evaluate shear-dependent and surface reactivity-dependent antithrombotic efficacy.
    Sakariassen KS; Hanson SR; Cadroy Y
    Thromb Res; 2001 Nov; 104(3):149-74. PubMed ID: 11672758
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A novel protease-activated receptor 1 inhibitor from the leech Whitmania pigra.
    Ren SH; Liu ZJ; Cao Y; Hua Y; Chen C; Guo W; Kong Y
    Chin J Nat Med; 2019 Aug; 17(8):591-599. PubMed ID: 31472896
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition effects of KRDS, a peptide derived from lactotransferrin, on platelet function and arterial thrombus formation in dogs.
    Wu G; Ruan C; Drouet L; Caen J
    Haemostasis; 1992; 22(1):1-6. PubMed ID: 1381697
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The in vivo pharmacological profile of CS-747, a novel antiplatelet agent with platelet ADP receptor antagonist properties.
    Sugidachi A; Asai F; Ogawa T; Inoue T; Koike H
    Br J Pharmacol; 2000 Apr; 129(7):1439-46. PubMed ID: 10742300
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of acetyl salicylic acid therapy on an experimental thrombosis induced by laser beam.
    Aguejouf O; Malfatti E; Belon P; Doutremepuich C
    Thromb Res; 2000 Sep; 99(6):595-602. PubMed ID: 10974346
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antithrombotic activity of Z4A5, a new platelet glycoprotein IIb/IIIa receptor antagonist evaluated in a rabbit arteriovenous shunt thrombosis model.
    Jing BB; Li YX; Zhang H; Ren ST; Wang M; Li YP; Zang WJ; Wang B
    Thromb Res; 2011 Nov; 128(5):463-9. PubMed ID: 21924458
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The saliva of the medicinal leech Hirudo medicinalis--II. Inhibition of platelet aggregation and of leukocyte activity and examination of reputed anaesthetic effects.
    Rigbi M; Levy H; Eldor A; Iraqi F; Teitelbaum M; Orevi M; Horovitz A; Galun R
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1987; 88(1):95-8. PubMed ID: 2890494
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Neurite-stimulating effect of Hirudo medicinalis salivary gland secreting factors in organotypic culture of the dorsal root ganglia].
    Chalisova NI; Baskova IP; Zavalova LL; Pennijainen VA
    Ross Fiziol Zh Im I M Sechenova; 2001 Jun; 87(6):815-20. PubMed ID: 11534208
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antiplatelet and antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa receptor antagonist.
    Mousa SA; Bozarth JM; Forsythe MS; Jackson SM; Leamy A; Diemer MM; Kapil RP; Knabb RM; Mayo MC; Pierce SK
    Circulation; 1994 Jan; 89(1):3-12. PubMed ID: 8281661
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
    Ramjit DR; Lynch JJ; Sitko GR; Mellott MJ; Holahan MA; Stabilito II; Stranieri MT; Zhang G; Lynch RJ; Manno PD
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1501-11. PubMed ID: 8371153
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antiplatelet and antithrombotic activity of L-3-n-butylphthalide in rats.
    Peng Y; Zeng X; Feng Y; Wang X
    J Cardiovasc Pharmacol; 2004 Jun; 43(6):876-81. PubMed ID: 15167282
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antiplatelet and antithrombotic effect of D-003.
    Molina V; Arruzazabala ML; Carbajal D; Más R; Valdés S
    Pharmacol Res; 2000 Aug; 42(2):137-43. PubMed ID: 10887042
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Repeat oral dosing of prasugrel, a novel P2Y12 receptor inhibitor, results in cumulative and potent antiplatelet and antithrombotic activity in several animal species.
    Niitsu Y; Sugidachi A; Ogawa T; Jakubowski JA; Hashimoto M; Isobe T; Otsuguro K; Asai F
    Eur J Pharmacol; 2008 Jan; 579(1-3):276-82. PubMed ID: 17996866
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo.
    Guth BD; Seewaldt-Becker E; Himmelsbach F; Weisenberger H; Müller TH
    J Cardiovasc Pharmacol; 1997 Aug; 30(2):261-72. PubMed ID: 9269956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.